We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Large Genome-Wide Association Study Identifies Novel Abdominal Aortic Aneurysm Risk Loci

By LabMedica International staff writers
Posted on 05 Oct 2020
A recent report identified novel genetic associations for abdominal aortic aneurysm (AAA) with therapeutic implications and identified a subset of the population at significantly increased genetic risk of AAA that was independent of family history.

AAA is a localized enlargement of the abdominal aorta such that the diameter is greater than three centimeters or more than 50% larger than normal. More...
They usually cause no symptoms, except during rupture. Rupture may result in pain in the abdomen or back, low blood pressure, or loss of consciousness, and often results in death. AAAs occur most commonly in men over 50 years old, and among those with a family history. Additional risk factors include smoking, high blood pressure, and other heart or blood vessel diseases. AAAs are the most common form of aortic aneurysm. In the United States, screening with abdominal ultrasound is recommended for males between 65 and 75 years of age with a history of smoking. The genetic determinants of AAA remain incompletely defined. In total, 10 previously identified risk loci explain only a small fraction of the inheritance of AAA.

Investigators at Stanford University (Palo Alto, CA, USA) and a large number of collaborators from other institutions performed a genome-wide association study (GWAS) on samples obtained from the Million Veteran Program. This program, which was initiated in 2011 and is now one of the world's largest genetic biobanks, was designed to promote the study of how genes affect the health of United States military veterans.

For the current study, the investigators performed a GWAS on nearly 18 million DNA sequence variants with AAA (7,642 cases and 172,172 controls) in veterans of European ancestry with independent replication in up to 4,972 cases and 99,858 controls. They then used Mendelian randomization to examine the causal effects of blood pressure on AAA. In addition, they examined the association of AAA risk variants with aneurysms in the lower extremity, cerebral, and iliac arterial beds, and derived a genome-wide polygenic risk score (PRS) to identify a subset of the population at greater risk for the disease.

Results revealed 14 novel genetic loci, bringing the total number of known significant AAA loci to 24. A genetic-linked increase of 10 millimeters of mercury (Hg) in diastolic blood pressure increased the risk of developing abdominal aortic aneurysm. Analysis showed further that 19 of the 24 risk loci for AAA were associated with aneurysms in other parts of the body. A 29-variant PRS was strongly associated with AAA, independent of family history and smoking risk factors. Using this PRS, the investigators identified a subset of the population with AAA prevalence greater than that observed in screening trials performed according to current guidelines.

"This study has doubled the number of genetic associations with abdominal aortic aneurysm, adding greatly to our understanding of the disease mechanisms," said senior author Dr. Philip S. Tsao, professor of cardiovascular medicine at Stanford University. "We were surprised that diastolic blood pressure, as opposed to systolic blood pressure, is likely of greater significance in the development of abdominal aortic aneurysm. This new information can enhance screening protocols and help identify individuals at risk for abdominal aortic aneurysm."

The AAA study was published in the September 28, 2020, online edition of the journal Circulation.

Related Links:
Stanford University


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
New
MR-proADM Test
B•R•A•H•M•S MR-proADM KRYPTOR test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: LVOne uses blood-based biomarkers to detect stroke and identify large vessel occlusion before hospital arrival, providing objective results earlier than traditional assessments. (Photo courtesy of UpFront Diagnostics)

First-of-Its-Kind Rapid Blood Test Gains CE Mark to Support Prehospital Stroke Triage

Rapid stroke identification before hospital arrival is critical because treatment efficacy declines with every minute of delay. However, definitive assessment typically requires hospital-based imaging,... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Ebola remains a rapidly evolving public health threat with high mortality, underscoring the need for timely diagnosis and decentralized testing closer to patients (Image Credit: Adobe Stock)

Collaboration Targets Blood-Based Ebola Detection Outside Central Laboratories

Co-Diagnostics, Inc. (Salt Lake City, UT, USA) and ReadyGo Diagnostics Ltd. (Bath, UK) have initiated a collaboration to evaluate ReadyGo’s GoCollect with the Co-Dx PCR platform for blood-based molecular... Read more

Pathology

view channel
Image: A new study demonstrates that vascular features in colorectal tumors could serve as prognostic biomarkers of disease outcome. (Image Credit: iStock)

Tumor Blood Vessel Features May Help Predict Colorectal Cancer Survival

Colorectal cancer outcomes vary widely, and tumor biology remains a key determinant of prognosis. Because neoplasms depend on a vascular supply, differences in intratumoral vessels may influence survival.... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: Central to the collaboration is the Enhanced Liver Fibrosis (ELF) test, a noninvasive blood test authorized in the U.S. to assess disease progression risk in patients with advanced fibrosis due to MASH and support patient management decisions. (Photo courtesy of Siemens Healthineers)

Siemens Healthineers and Novo Collaborate to Expand Access to Noninvasive Liver Testing

Metabolic dysfunction‑associated steatotic liver disease (MASLD) and its progressive form, metabolic dysfunction‑associated steatohepatitis (MASH), affect millions and are linked to obesity, type 2 diabetes,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.